Journal ID (nlm-ta): Nat Commun
Journal ID (iso-abbrev): Nat Commun
Title:
Nature Communications
Publisher:
Nature Publishing Group UK
(London
)
ISSN
(Electronic):
2041-1723
Publication date
(Electronic):
18
November
2021
Publication date PMC-release: 18
November
2021
Publication date Collection: 2021
Volume: 12
Electronic Location Identifier: 6726
Affiliations
[1
]GRID grid.168010.e, ISNI 0000000419368956, Department of Microbiology & Immunology, , Stanford University School of Medicine, ; Stanford, CA 94305 USA
[2
]GRID grid.168010.e, ISNI 0000000419368956, Department of Dermatology, , Stanford University School of Medicine, ; Stanford, CA 94305 USA
[3
]GRID grid.168010.e, ISNI 0000000419368956, Department of Pathology, , Stanford University School of Medicine, ; Stanford, CA 94305 USA
[4
]GRID grid.168010.e, ISNI 0000000419368956, Department of Bioengineering, , Stanford University Schools of Engineering and Medicine, ; Stanford, CA 94305 USA
[5
]GRID grid.38142.3c, ISNI 000000041936754X, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard
Medical School, ; Boston, MA 02215 USA
[6
]GRID grid.270240.3, ISNI 0000 0001 2180 1622, Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, ; Seattle, WA USA
[7
]GRID grid.168010.e, ISNI 0000000419368956, Division of Oncology, , Stanford University School of Medicine, ; Stanford, CA 94305 USA
[8
]GRID grid.411544.1, ISNI 0000 0001 0196 8249, Department of Pathology and Neuropathology, , University Hospital and Comprehensive Cancer Center Tübingen, ; Tübingen, Germany
Author information
Article
Publisher ID:
26974
DOI: 10.1038/s41467-021-26974-6
PMC ID: 8602403
PubMed ID: 34795254
SO-VID: e1c4af6b-3563-4349-b624-9e65d7664034
Copyright © © The Author(s) 2021
License:
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium
or format, as long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if changes were
made. The images or other third party material in this article are included in the
article’s Creative Commons license, unless indicated otherwise in a credit line to
the material. If material is not included in the article’s Creative Commons license
and your intended use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright holder. To view
a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/.
Funded by: This work was supported by the National Institutes of Health (NIH) 2U19AI057229-16,
5P01HL10879707, 5R01GM10983604, 5R33CA18365403, 5U01AI101984-07, 5UH2AR06767604, 5R01CA19665703,
5U54CA20997103, 5F99CA212231-02, 1F32CA233203-01, 5U01AI140498-02, 1U54HG010426-01,
5U19AI100627-07, 1R01HL120724-01A1, R33CA183692, R01HL128173-04, 5P01AI131374-02,
5UG3DK114937-02, 1U19AI135976-01, IDIQ17X149, 1U2CCA233238-01, 1U2CCA233195-01 (G.P.N.),
F32CA233203 (D.P.), T32AR007422 (D.P.), T32AI007290 (G.L.B.); The National Cancer
Institute: U01CA154967 and UM1CA154967 (M.A.C., S.P.F.); Cancer Center Support Grant
P30 CA015704 (M.A.C., S.P.F). The Department of Defense (W81XWH-14-1-0180 and W81XWH-12-1-0591)
(G.P.N.); The Food and Drug Administration (HHSF223201610018C and DSTL/AGR/00980/01)
(G.P.N.); Cancer Research UK (C27165/A29073) (G.P.N.); The Bill and Melinda Gates
Foundation (OPP1113682) (S.J., G.P.N.); The Cancer Research Institute (G.P.N.); The
Parker Institute for Cancer Immunotherapy (G.P.N.); The Kenneth Rainin Foundation
(2018-575) (G.P.N.); Celgene, Inc. (133826 and 134073) (G.P.N.); the Rachford & Carlotta
A. Harris Endowed Chair (G.P.N.); and The Beckman Center for Molecular and Genetic
Medicine (D.P., C.M.S., Y.H.K, G.P.N.).
